Vaccine Therapy in Treating Patients With Metastatic Melanoma

Clinical trial NCT00087373 · TERMINATED

Trial details

NCT number: NCT00087373
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma

Start date: 2004-06-01
Primary completion: 2006-02-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.